期刊文献+

HPLC-MS/MS鉴定创新药物艾托莫德的有关物质 被引量:3

Identification of Related Substances in a New Drug Aituomode by HPLC-MS/MS
原文传递
导出
摘要 目的对抗银屑病新药艾托莫德原料药中的7种有关物质Imp-A^Imp-G进行结构鉴定。方法利用高效液相色谱-四级杆线性离子阱质谱联用法(HPLC-QTrap-MS)推测各有关物质的结构,高效液相色谱-四级杆飞行时间质谱联用法(HPLCQTOF/MS)技术快速确证各结构的相对分子质量及分子组成。结果获得了艾托莫德原料药中的7种有关物质Imp-A^ImpG的相对分子质量及结构式。结论方法快速、简便,为原料药的杂质解析提供了良好的思路,并为创新药物艾托莫德的有关物质研究及质量控制提供了有意义的实验数据和参考依据。 OBJECTIVE To identify the related substances in aituomode bulk drug. METHODS HPLC-QTrap-MS and HPLC- QTOF-MS were used to determine seven kinds of related substances denoted by Imp-A to Imp-G. RESULTS The structures and molecular weights of the related substances in aituomode were identified. CONCLUSION The method is simple and accurate, providing a good idea for the identification of the related substances in bulk drugs. The experimental data are valuable to the determination of the related substances and quality control of aituomode.
出处 《中国药学杂志》 CAS CSCD 北大核心 2017年第1期68-71,共4页 Chinese Pharmaceutical Journal
基金 中央级公益性科研院所基本科研业务费专项基金资助项目(2015CX09)
关键词 艾托莫德 高效液相色谱-四级杆飞行时间质谱联用法 有关物质 生产工艺 aituomode HPLC-QTOF/MS related substances production technologie
  • 相关文献

参考文献2

二级参考文献42

  • 1Fung JJ,Alessiani M,Abu-Elmagd K,et al.Adverse effects associated with the use of FK 506[J].Transplant Proc, 1991,23(6):3 105-3 108.
  • 2Rosen H,Gonzalez-Cabrera PJ,Sanna MG,et al.Sphingosine 1-phosphate receptor signaling[J].Annu Rev Biochem,2009,78(1):743-768.
  • 3Oo ML,Chang SH,Thangada S,et al.Engagement of S1P(1)-degradative mechanisms leads to vascular leak in mice[J].J Clin Invest,2011,121(6):2 290-2 300.
  • 4Oo ML,Thangada S,Wu MT,et al.Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor[J].J Biol Chem,2007,282(12):9 082-9 089.
  • 5Chiba K.FTY720,a new class of immunomodulator,inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors[J].Pharmacol Ther,2005,108(3):308-319.
  • 6Brinkmann V, Billich A, Baumruker T, et al. Fingolimod(FTY720):discovery and development of an oral drug to treat multiple sclerosis[J].Nat Rev Drug Discov,2010,9(11):883-897.
  • 7Suzuki K,Yan H,Li XK,et al.Prevention of experimentally induced autoimmune type I diabetes in rats by the new immunosuppressive reagent FTY720[J].Transplant Proc,1998,30(4):1 044-1 045.
  • 8Tsunemi S,Iwasaki T,Kitano S,et al.Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model[J].Clin Immunol,2010,136(2):197-204.
  • 9Wang F,Tan W,Guo D,et al.Reduction of CD4 positive T cells and improvement of pathological changes of collagen-induced arthritis by FTY720[J].Eur J Pharmacol,2007,573(1/2/3):230-240.
  • 10Billich A,Bornancin F,Devay P,et al.Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases[J].J Biol Chem,2003,278(48):47 408-47 415.

共引文献3

同被引文献101

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部